OL投稿流程.docx
- 文档编号:23068491
- 上传时间:2023-04-30
- 格式:DOCX
- 页数:10
- 大小:19.85KB
OL投稿流程.docx
《OL投稿流程.docx》由会员分享,可在线阅读,更多相关《OL投稿流程.docx(10页珍藏版)》请在冰豆网上搜索。
OL投稿流程
OL投稿流程
去美国化学会主页申请一个帐号(密码千万不要不记得)
第二:
进入投稿系统
上载投稿信,文章(OL有规定的摸板),支持材料(一定要有元素分析哦,没有的话,高辨论质谱能够取代)
投稿信(这是我的仅供参考)
DearEditorsandReferees:
The*************isausefulmethodfortheproductionof***************whichareimportantpharmaceuticalintermediates.Itisknownthatthe*****************hasbeenachievedwithexcellentenantioselectivity.Insharpcontrast,theuseof*********************hasbeenprovenmuchmorechallenging.Asaresult,few****havebeenreportedto******************.*********reporteda*************************withmoderateyieldsandenantioselectivities.However,the******************issubstantiallylesseffectivefor*****substrates.Inthesameyear,*****andhisco-workersdescribedthe************inthepresenceof***************withhighenantioselectivitiesandyields.Subsequently,************andourgrouphavereported*************.Althoughtheadvanceshavebeenachieved,************,*************,orother**********mustbeemployed.Here,wereportedaefficientsystemfor*****************.
a)Thisisthefirstexampleofhighlyefficient*********whichcould**********************.
b)Our********employsnoadditional************orthe**************.Thishasgreatlysimplifiedtheexperimentalprocedureforthisreaction.
WewouldliketosubmitthemanuscripttoOrg.Lett(communication)forpublication.Itwouldbehighlyappreciatedifyougiveafavorableconsiderationonit.
Sincerelyyours,
第三:
文章投出
系统回复:
>DearDr.:
Yourmanuscript
ManuscriptTitle:
****************************************wasreceivedintheeditorialofficesofOrganicLetterson10-MAR-05.
ThankyouforsubmittingyourworktoOrganicLetters.
SubmissionofamanuscripttoOrganicLettersimpliesthattheworkreported
thereinhasnotreceivedpriorpublicationandisnotunderconsiderationfor
publicationelsewhereinanymedium,includingelectronicjournalsandcomputer
databasesofapublicnature.Thismanuscriptisbeingconsideredwiththe
understandingitissubmittedonanexclusivebasis.Ifotherwise,pleaseadvise.
Whenyourmanuscripthasbeenassignedaneditor,youwillreceiveasecondemail
copyrightform.
IfyousubmittedthismanuscriptastheCorrespondingAuthor,youmayfindit
convenienttoshareyoursecuritykey.Thesecuritykeyallowsoneotherperson
tosubmitarevisiontothemanuscriptand/ortrackthemanuscript'sstatuson
theirownParagonhomepage.
Ifthemanuscriptwassubmittedonyourbehalf,itsstatusdoesnotcurrently
displayonyourParagonhomepage.Usethesecuritykeytoaddthismanuscriptto
yourParagonhomepage.
PleaserememberthatonlytheCorrespondingAuthorandoneotherpersonmaytrack
amanuscript'sstatusatonetime.
Sincerely,
Editor-in-Chief,OrganicLetter
一样翌日就会给你分主编,你能够进你的投稿主页上看到分配给你的主编.
这时,你的进美国化学会下载版权,签名后(要紧是第一作者和通讯作者)发往分配给你的主编.这一点专门重要,因为你不发版权,主编就可不能给你送审稿人!
!
!
!
!
!
第四
如果你在审稿期间通过系统跟踪你的文章
会有以下回复:
Thisemailistoinformyouthatthepersonwhoistrackingyourmanuscript"************************************************",************haschanged.
trackedby*****.
Pleaserememberthatonlytwopeople,theCorrespondingAuthorandoneother
person,maytrackamanuscriptatonetime.Ifyouchoosetoshareyour
manuscriptnumberandsecuritykeywithadditionalpartiesforthepurposeof
tracking,thenewerpartywilloverwriteanypreviouspersonwhowastrackingthe
manuscript.Newpartieswillnotoverwriteyourabilitytotrackyour
manuscript.
没有关系,意思是讲只承诺你和通讯作者跟踪文章
第五:
文章有消息(一样一个月)
DearProf.***:
YourpaperhasbeenreviewedandIwouldbehappytoacceptitafter
theattachedreviewercommentsandtheitemsindicatedontherevision
requestformhavebeenaddressed.Pleaseincludeadetailedletterwith
yourrevision,itemizingthechangesyouhavemadeinthemanuscript.
TOREVISEYOURMANUSCRIPTONTHEWEB:
-------------------------------------
NOTE:
PleasesubmityourrevisionusingyourParagonhomepage.
1.LogontoyourParagonhomepageathttp:
//paragon.acs.org.
2.Scrolltothesectiontitled:
'Revisionsrequiredby
EditorialOffice.'
-Clickonthemanuscriptnumber*tosubmitarevision.
3.FollowthedirectionsinParagontocompletethesubmission
ofyourrevision.
[*Intheeventthismanuscriptisnotlistedonyourhomepage:
-Clickonthe'ReviseManuscript'buttontoaddthe
manuscripttoyourhomepageandrevisethemanuscript
-Enterthemanuscriptnumberandsecuritykeyasfollows:
ManuscriptNumber:
*******
NOTE:
Allmanuscriptnumbersbeginwiththeletters
'ol'followedby6numbers.Thelast
charactercanbeeitheraletter,anumber,
ora'+'sign.
SecurityKey:
******
-Clickon"AddPaper"
-Themanuscriptshouldnowappearinthe
'RevisionsrequiredbyEditorialOffice'section
Continuewithsteps2and3above.]
SubmittingSupportingInformation(SI):
AtStep3ofthesubmissionprocess,'UploadDocuments',youwillseea
listofalloftheSIfilesyouoriginallysubmitted.Youcanaddor
deletefiles.Ifyouhavechangedafile,youmustremoveitandupload
thenewversion.Youmustsubmitamanuscriptinordertosubmit
revisedSI.(Iftherearenochangestoyourmanuscript,simply
resubmittheoriginalmanuscript.)
Asyouknow,OrganicLettersaimsforquickturnaroundtimefrom
submissiontopublication;therefore,weaskthatyoucompleteyour
revisionwithin7days.Pleaseletusknowifyouneedmoretime.We
willpublisharevisiondateifrevisiontakesover30days,unless
thereareextenuatingcircumstances.
Sincerely,
审稿意见:
1#
RecommendationsregardingthemanuscriptMSNO:
***********
2.________Publishafterminorrevisionsnotedbelow
Overallimportanceofthispaper–8/10
Themanuscript**************by******andcoworkerssuggestsanovelmethodologyfor*******to*********8withlowligandloading.Thisworkcontributestoanintensivelyinvestigatedfieldofenantioselective************.Inparticular,additionof************stilllacksnoteworthyachievementsintermsofenantiomericpurityoftertiarypropargylicalcohols,obtainedinthistransformnation.Theligandsutilizedinthismanuscriptarestraightforwardlysynthesizedfromcommercialaminoacidsandusedinremarkablylowcatalyticquantities,ascomparedtothemethodsreportedsofar.Enantiomericpuritiesoffinalproductsaswellasisolatedyieldsareintherangeofreasonabletohigh.Thedescribedmethodologydoesn’trequireuseofadditionalLewisacid,thussimplifyingtheoverallprocess.Thediscussedmanuscriptisrecommendedforpublicationwithminorrevisionspresentedbelow.
Commentsreferringtothemanuscript:
·Severalsentencesarebadformulatedandshouldbephraseddifferently
·Severalgrammarmistakeswerefoundinthepresenttext
·Severalmisspellingswerefoundinthereferencespartandshouldbeommited(i.e.,namesofjournalsaswellasnamesofauthors)
·References9(k)wasnotfoundontheindicatedpage(JACS,2005,127,3137).Thispaperappearsonthepage1313oftheindicatedissue.
·Scheme2:
Itisrecommendedtoadd“R=***”and“R=*****”tothecompounds**and***respectively,tomaketheSchememoreclear
·Ligand***appearsinFigure1,althoughnospeciesunderthisnumberarementionedinthetext
·Table1–it’srecommendedtoaddafootnotewiththeamountofsubstrateusedinthistransformation,otherwisethestoichiometryofdiethylzincisunclear
Commentsreferringtotheexperimentalpart:
·FromTable1onecanconcludethatthereactionisconductedat-18Cfor48h.Itappears,however,inthesyntheticprotocol,thatthereactionmixturewasactuallystirredatr.t.for********.
·Formoreconvenientreadingandcorrelatingbetweenthedatainthetextandintheexperimentalpart,it’srecommendedtoassignnumberstotheobtainedproducts
·ThechiralHPLCcolumnusedinthepresentworkforee%determinationismentionedasChiracelOD-Hinthetext,butChiracelODintheexperimentalpart
2#
ManuscriptNumber:
********
ManuscriptTitle:
************
AlcoholsCorrespondingAuthor:
********
RatetheoverallimportanceofthispapertothefieldofOrganicChemistry
10-HighImportance/1-LowImportance:
8
Recommendation:
Publishafterminorrevisionsnotedbelow.
AdditionalComments:
Themanuscript"*****************************"by**************andcoworkerisaquiteinterestingandusefulpieceofwork.Wangandcoworkerswereabletofindasuitable,easilypreparedandinexpensiveligandthatmakepossibletheadditionofacetylidestoketonesinverylowloading.Theseareun-precedentresultsthatcouldopennewperspectiveintheformationofquaternarystereocenters.In-fact,animmediateextensiontothepresentcommunicationisthebehavioroftheligandsinadditionofsimple*******,functionalizedzincreagents,or*********8reagentsto********.Untilnow,onlyfewsuccessfulstudieshasbeenpublishedby****,*******and**********.************8'sligandprobablycanbealsousedintheseprocesses,andtherefore,thispaperishighlyrecommendedforOrg.Lett.
Minorpoints.Inanoteacommentaboutthereactivityofaliphaticketonecouldbeusefultoreaders.
Innote,therearecorrectiontointroduce:
Reference1(b).ComeprehensiveAsymmetricCatalysis.
Reference2(k).Hems,andpublicationsyear2006.
Reference3(g).************.;
Reference3(k).*******.;
9(e).Yorozu,K
Reference9(f).Authorsaremissing:
(f)Belokon',Y,R.;Caveda-Cepas,S.;Green,B.;Ikonnikov,N.S.;Khrustalev,V.N.:
Larichev,V.S.;Moscalenko,M.A.;North,M.;Orizu,C.;Tararov,V.I.;Tasinazzo,M.;TimofeevaG.I.,Yashkina,L.V.3968-3973.
Reference9(h).Irvine,D.J.
Reference9(i).KevinW.Kuntz.
Reference9(k).J.Am.Chem.S
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- OL 投稿 流程